VJHemOnc is committed to improving our service to you

ASCO 2019 | Resonate: Ibrutinib associated with favourable PFS and OS in CLL

VJHemOnc is committed to improving our service to you

Susan O’Brien

Susan O’Brien, MD, of the University of California Irvine, Irvine, CA, discusses the results of the chronic lymphocytic leukemia (CLL)
RESONATE and RESONATE-2 study at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter